Neonatal cancer is an uncommon disease that comprises of a broad variety of neoplasms with a wide range of histological characteristics. Almost all kinds of pediatric cancer can affect fetuses and newborns however the presentation and behavior of neonatal tumors differs significantly from that of older children resulting in disparities in diagnosis and treatment. Although the origins of neonatal cancer are unknown, genetic factors are likely to play a role. Other congenital anomalies are also present.
"Childhood cancer" is a broad phrase that refers to a variety of cancers and noncancerous tumors that affect children. Pediatric cancer is another name for childhood cancer. Cancer can develop in any part of the body including the blood and lymphatic systems, the brain and spinal cord (central nervous system), kidneys and other organs and tissues in children.
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Hospital care for cancer patients - safety, quality of care, education and respect for patient’s rights
Mariola Wioletta Borowska, Maria Sklodowska-Curie National Research Institute of Oncology, Poland
Title : Importin7 induces M2 macrophage and promotes the progress of colorectal cancer by regulating the nucleus translocation of GRP78
Changjiang Yang, Peking University People's Hospital, China
Title : Cancer-associated fibroblasts derived soluble CADM1 predicts response to neoadjuvant chemoimmunotherapy in lung cancer
Jian Li, Shanghai Jiaotong University, China